Year
Edition number
№3-4 / 2016
ORIGINAL PAPERS
V.A. Yurova, N.L. Kozlovskaya
Membranoproliferative glomerulonephritis: a new classification and pathogenesis4-10
E.F. Barinov
Platelet reactivity in chronic obstructive pyelonephritis: role of adrenaline in the pathogenesis of complications11-15
A.G. Burmagina, A.Yu. Nikolaev
Prehypertension as a risk factor for chronic kidney disease16-21
E.V. Bolotova, A.V. Dudnikova, L.F. Eremeeva, S.A. Kartavenkov
Features of intrarenal blood flow in patients with chronic obstructive pulmonary disease22-26
A.G. Stolyar, L.N. Budkar, N.F. Klimusheva, S.I. Solodushkin, N.A. Tomilina
Posttransplatation predictors of results of kidney transplantation27-41
A.A. Yakovenko, A.Sh. Rumyantsev, A.M. Esayan
New approaches to the correction of malnutrition in patients receiving chronic hemodialysis treatment42-45
PAEDIATRIC NEPHROLOGY
N.M. Mikheeva, Ya.F. Zverev, G.I. Vykhodtseva, Yu.F. Lobanov, V.P. Tokarev
Metabolic disorders of the urinary system in children with acute abdominal pain syndrome46-48
Epidemiology and prevention
D.O. Dragunov, A.V. Sokolova, T.V. Latyshev, G.P. Arutyunov
Prevalence of chronic kidney disease in comorbid patients49-52
CASE REPORTS
A.G. Yankovoy, E.I. Prokopenko, A.A. Sinyutin, V.A. Stepanov
Neoplastic disease of the transplanted kidney53-59
A.G. Yankovoy, A.A. Sinyutin, V.A. Stepanov
Angiomyolipoma of own recipient’s kidney after allotransplantation of cadaveric kidney60-62
E.I. Prokopenko, V.V. Likhvantsev, A.V. Vatazin, A.F. Lopatin, V.M. Guryeva, E.I. Ostrovsky, A.M. Fomin, O.N. Ulitkina
Pregnancy-associated atypical hemolytic uremic syndrome: life-saving therapy with ekulizumab63-68
A.G. Yankovoy, A.E. Ivanov, S.B. Urenkov
Nephrolithiasis of transplanted kidney69-74
LITERATURE REVIEWS
E.V. Bolotova, V.V. Yavlyanskaya, A.V. Dudnikova
Mineral and bone disorders in patients with chronic obstructive pulmonary disease combined with chronic kidney disease75-79
M. M. Batushin
The use of ketoacids in chronic kidney disease80-83
V.M. Ermolenko, N.N. Filatova
New iron-containing phosphate-binding agents for the correction of hyperphosphatemia in patients with chronic kidney disease84-87
